Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy | Zendy

Fabrice Barlési | Zendy; C. Doddoli | Zendy; Jean-Philippe Torre | Zendy; R Giudicelli | Zendy; P. Fuentès | Zendy; P. Thomas | Zendy; Philippe Astoul | Zendy

Open Access

Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy

Author(s) -

Fabrice Barlési,

C. Doddoli,

Jean-Philippe Torre,

R Giudicelli,

P. Fuentès,

P. Thomas,

Philippe Astoul

Publication year - 2005

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2005.06.018

Subject(s) - medicine , surgery , stage (stratigraphy) , lung cancer , proportional hazards model , mediastinal lymph node , survival analysis , lymph node , cancer , gastroenterology , metastasis , paleontology , biology

Induction Therapy (IT) before surgery emerged as a widely used strategy for IIIAN2 and selected IIIB NSCLC patients. However, IT is associated with a possible increase in postoperative complications. Consequently, selection of patients with the best chances to benefit from combined treatment is mandatory.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research